Medlumics lands a 14M€ new financing round - ANDERA PARTNERS : ANDERA PARTNERS

Welcome Asabys, VI Partners and CDTI

To read Medlumics’ press release, please click here.

More news

24.07.2023 - andera Life Sciences - Press releases

Crescendo Biologics secures $32M and announces expansion of CB307 Phase 1b trial in PSMA+ solid tumo…

27.06.2023 - andera Life Sciences - Press releases

Allecra Therapeutics Submits New Drug Application to the U.S. FDA for EXBLIFEP® for the Treatment of…

01.06.2023 - andera Life Sciences - Press releases

Inotrem announces publication of two key articles on nangibotide Phase II programs in peer-reviewed…

15.05.2023 - andera Life Sciences - Press releases

Andera Partners co-leads a €40 million Series A of Dualyx, a Belgian biotech developing novel Treg t…

20.04.2023 - andera Life Sciences - Press releases

Tubulis Announces Strategic License Agreement with Bristol Myers Squibb to Develop Next Generation A…

18.04.2023 - andera Life Sciences - Press releases

Andera Partners co-leads a Series A extension round of € 47.75 million for radiopharmaceutical compa…

13.04.2023 - andera Life Sciences - Press releases

Andera Partners leads $48.5 Million Series A financing for medical device company BioVentrix®

29.03.2023 - andera Life Sciences - Press releases

Grey Wolf Therapeutics Announces Dosing of First Patient in Phase 1/2 Clinical Study of GRWD5769 in…

15.03.2023 - andera Life Sciences - Press releases

Andera Partners co-leads $25m extension round for FIRE1

03.03.2023 - andera Life Sciences - Press releases

Flamingo Therapeutics and Dynacure Announce Merger to Create Leading RNA Therapeutics Company Focuse…

13.02.2023 - andera Life Sciences - Press releases

Andera Partners Portfolio Company Mineralys Therapeutics Successfully Completes Upsized $192 Million…

02.02.2023 - andera Life Sciences - Press releases

Agomab Reports Positive Phase 1 Results with AGMB-129, a GI-restricted ALK5 Inhibitor for Fibrosteno…

26.01.2023 - andera Life Sciences - Press releases

Andera Partners Participates in the €45 Million Series B Financing of Grey Wolf Therapeutics

10.01.2023 - andera Life Sciences - Press releases

Andera Partners invests in SoniVie, a medtech company developing a promising device for the treatmen…

09.01.2023 - andera Life Sciences - Press releases

Andera Partners participates in the $138 Million Series C Financing of Amolyt Pharma